Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis

Journal of the American Academy of Dermatology

Volumn 62, Issue 5, 2010, Pages 874-879

  Ahdout, Jennifer ^a   Haley, Jennifer C ^a   Chiu, Melvin W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adalimumab; erythema multiforme; inhibitor; psoriasis; TNF

Indexed keywords

ADALIMUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; METHOTREXATE; PREDNISONE; PSORALEN; SALAZOSULFAPYRIDINE; STEROID; VALACICLOVIR;

AGED; ANAMNESIS; ARTICLE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS VULGARIS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

AGED; ANTIBODIES, MONOCLONAL; ERYTHEMA MULTIFORME; HUMANS; IMMUNOGLOBULIN G; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950593320     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.04.048     Document Type: Article

References (23)

1. Tzu J., and Kerdel F. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Dermatol Ther 21 (2008) 131-141
2. van de Kerkhof P.C. Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments. J Eur Acad Dermatol Venereol 20 (2006) 639-650
3. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., and Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117 (2008) 244-279
4. Chang J., and Girgis L. Clinical use of anti-TNF-alpha biologic agents-a guide for GPs. Aust Fam Physician 36 (2007) 1035-1038
5. FDA Drug Safety Newsletter. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/dsn/2008_winter/toc.htm. Accessed January 10, 2009.
6. Kain T., MacGregor D., Buchanan R.R., de Jager J.P., and Schachna L. Erythema multiforme with tumor necrosis factor inhibitors: a class effect?. Ann Rheum Dis 61 (2002) 850-851
7. Soliotis F., Glover M., and Jawad A.S. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 67 (2008) 899-900
8. Vergara G., Silvestre J.F., Betlloch I., Vela P., Albares M.P., and Pascual J.C. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 138 (2002) 1258-1259
9. Huff J.C., and Weston W.L. Isomorphic phenomenon in erythema multiforme. Clin Exp Dermatol 8 (1983) 409-413
10. Habif T.P. Erythema multiforme. In: Habif T.P. (Ed). Clinical dermatology (2004), Mosby, Edinburgh (UK) 627-628
11. Villiger R., von Vigier R.O., Ramelli G.P., Hassink R.I., and Bianchetti M.G. Precipitants in 42 cases of erythema multiforme. Eur J Pediatr 158 (1999) 929-932
12. Kokuba H., Aurelian L., and Burnett J. Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-γ is expressed in HAEM lesions and tumor necrosis factor-α in drug induced erythema multiforme lesions. J Invest Dermatol 113 (1999) 808-815
13. Aurelian L., Kokuba H., and Burnett J.W. Understanding the pathogenesis of HSV-associated erythema multiforme. Dermatology 19 (1998) 219-222
14. Burnett J.W., Laing J.M., and Aurelian L. Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses. Arch Dermatol 144 (2008) 902-907
15. Humira (adalimumab) [package insert]. U.S. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/foi/label/2002/adalabb123102LB.htm. Accessed January 10, 2009.
16. Enbrel (etanercept) [package insert]. U.S. Food and Drug Administration Website. Available at: http://www.fda.gov/cder/foi/label/2008/103795s5359lbl.pdf. Accessed January 10, 2009.
17. Domm S., Cinati J., and Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol 159 (2008) 1217-1228
18. Justice E.A., Khan S.Y., Logan S., and Jobanputra P. Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving Infliximab: a case report. J Med Case Reports 2 (2008) 282
19. Ng P.P., Sun Y.J., Tan H.H., and Tan S.H. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology 207 (2003) 349-353
20. Bourrain J.L., Woodward C., Dumas V., Caperan D., Beani J.C., and Amblard P. Natural rubber latex contact dermatitis with features of erythema multiforme. Contact Dermatitis 35 (1996) 55-56
21. Bara C., Milpied B., Geraut C., and Stalder J.F. Erythema multiforme with occupational rubber contact sensitivity. Contact Dermatitis 49 (2003) 269-270
22. Lu C.Y., and Sun C.C. Localized erythema-multiforme-like contact dermatitis from rubber gloves. Contact Dermatitis 45 (2001) 311-312
23. Tatfall F., Schofield J., and Leigh I. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 132 (1995) 267-270